Robert Cozens

803 total citations
3 papers, 475 citations indexed

About

Robert Cozens is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Robert Cozens has authored 3 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Cancer Research and 1 paper in Oncology. Recurrent topics in Robert Cozens's work include Cancer, Hypoxia, and Metabolism (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). Robert Cozens is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). Robert Cozens collaborates with scholars based in Switzerland and United States. Robert Cozens's co-authors include Stephan Ruetz, Mark Pearson, Diana Graus Porta, Juergen Mestan, Hans‐Georg Capraro, Carlos Garcı́a-Echeverrı́a, Josef Brueggen, Francesco Hofmann, Doriano Fabbro and Janis Liebetanz and has published in prestigious journals such as Cancer Cell, Cancer Research and European Journal of Biochemistry.

In The Last Decade

Robert Cozens

3 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Cozens Switzerland	2	330	228	142	126	56	3	475
Danielle P. Johnson United States	5	273 0.8×	180 0.8×	97 0.7×	99 0.8×	54 1.0×	7	387
Darla Landfair	5	241 0.7×	107 0.5×	75 0.5×	66 0.5×	34 0.6×	8	370
Craig I. Campbell Canada	11	297 0.9×	134 0.6×	251 1.8×	146 1.2×	38 0.7×	18	458
Greg Friberg United States	10	259 0.8×	108 0.5×	189 1.3×	95 0.8×	116 2.1×	15	488
Golareh Habibi Canada	5	430 1.3×	150 0.7×	241 1.7×	151 1.2×	45 0.8×	7	582
Jurriaan Brouwer‐Visser United States	12	239 0.7×	66 0.3×	170 1.2×	121 1.0×	46 0.8×	46	495
Sandeep Kumar Parvathareddy Saudi Arabia	15	280 0.8×	208 0.9×	213 1.5×	139 1.1×	84 1.5×	57	626
Hitoshi Funatomi Japan	10	382 1.2×	132 0.6×	314 2.2×	131 1.0×	27 0.5×	25	640
Wioletta Pękala Poland	11	505 1.5×	85 0.4×	192 1.4×	230 1.8×	45 0.8×	15	689
Antonella Marzullo Italy	9	92 0.3×	202 0.9×	89 0.6×	64 0.5×	37 0.7×	22	376

Countries citing papers authored by Robert Cozens

Since Specialization

Citations

This map shows the geographic impact of Robert Cozens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Cozens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Cozens more than expected).

Fields of papers citing papers by Robert Cozens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Cozens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Cozens. The network helps show where Robert Cozens may publish in the future.

Co-authorship network of co-authors of Robert Cozens

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Cozens. A scholar is included among the top collaborators of Robert Cozens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Cozens. Robert Cozens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Evans, Dean B. & Robert Cozens. (2010). Abstract 3859: Evaluation of addition of the tumor-vascular disrupting agent ASA404 (vadimezan) to paclitaxel and carboplatin and the influence of subsequent ASA404 maintenance therapy using a human NSCLC xenograft model. Cancer Research. 70(8_Supplement). 3859–3859. 1 indexed citations

2.

Garcı́a-Echeverrı́a, Carlos, Mark Pearson, Andreas Marti, et al.. (2004). In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell. 5(3). 231–239. 447 indexed citations

3.

McGlynn, Elaine, et al.. (1992). Large‐scale purification and characterisation of a recombinant epidermal growth‐factor receptor protein‐tyrosine kinase. European Journal of Biochemistry. 207(1). 265–275. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact